This National Institute for Health and Care Excellence (NICE) guideline covers the care and treatment of adults (aged 18 and over) with type 1 diabetes.
Type 1 diabetes affects over 370,000 adults in the UK. One of the most important roles of healthcare professionals providing diabetes care to adults with type 1 diabetes is to ensure that systems are in place to provide informed, expert support, education and training for insulin users, as well as a range of other more conventional biomedical services and interventions.
NICE last produced a guideline on type 1 diabetes in 2004 (NICE clinical guideline 15). Since then, life expectancy for adults living with type 1 diabetes has increased, but it remains significantly shorter than for people without diabetes. There remain important deficiencies in care provision, most adults with type 1 diabetes have HbA1c above target levels, and rates of diabetic ketoacidosis (the acute complication of insulin deficiency) and renal failure have increased. This update focuses on areas where new knowledge and treatment opportunities have arisen in the last decade. These include improvements in technology to support better glucose levels, that should result in improved outcomes for adults with type 1 diabetes. These changes also present more challenges in terms of the diversity and complexity of the tools that can now be provided, and this guideline describes evidence‑based best practice for their deployment.
Topics updated from the 2004 guideline include:
The following topics were not included in 2004 and have been added:
You can read the guideline on NICE's website.